Innovative Leadership With recent leadership changes including the appointment of a new President and Chairman, AI Medical Service Inc. demonstrates a commitment to strategic growth and innovation, making it an attractive partner for organizations seeking cutting-edge medical AI solutions.

Growing Recognition The company's receipt of the METI Minister's Award and inclusion in Forbes Asia 100 To Watch 2024 highlights its increasing industry credibility and market visibility, opening opportunities for sales with government, healthcare institutions, and investors seeking reputable partners.

Research Collaborations Active joint research agreements with Mahidol University and the Chinese University of Hong Kong indicate the company's focus on international collaboration and development, which can facilitate access to new markets and diverse research-based sales channels.

Product Launch The launch of their first AI software product aimed at early detection of stomach cancer presents a direct sales opportunity to hospitals, clinics, and diagnostic centers focused on gastrointestinal health and cancer screening advancements.

Funding Prospects Backed by significant funding of 43 million USD led by major investors like SoftBank Vision Fund 2, AI Medical Service Inc. is positioned for rapid expansion and product commercialization, offering potential for strategic sales partnerships in the healthcare AI space.